P4HB and esophageal squamous cell carcinoma: Additionally, the observed reversal of these phenomena by the P4HB inhibitor, CCF642, provides compelling evidence of the significant involvement of P4HB in the progression of ESCC b via regulating PHGDH/Bcl-2/caspase-3 pathway (Fig. 3).